Safety & Performance of the World Medica World Diverter Embolization Device

Starting soon · Not applicable

Conditions studied: Intracranial Aneurysm

In brief

The objective of this study is to investgiate the safety and clinical performance of the World Diverter Emoblization Device for the endovascular treatment of wide-neck (neck width ≥ 4 mm or dome-to-neck ratio \<2) or fusiform intracranial aneurysms in the internal carotid artery (ICA) from the petrous segment to the terminus arising from a parent vessel with a diameter ≥ 2.5 mm and ≤ 5.5 mm.

Key facts

Study ID: NCT07339358
Run by: World Medica USA, LLC
People needed: 72
Starts: 2026-03-31
Expected to finish: 2028-08-31
Last updated by the study team: 2026-01-14

Who can join

Age: 22 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Age 18 22 to 80 years
Subject, or subject's legal representative provided informed consent
Subject agrees to the requirements of the study, including returning for required follow-up visits
Parent artery diameter of 2.0-5.5 mm distal and proximal to the target IA
Subject has a single target IA in the index procedure with the following characteristics: (1) Unruptured; (2) Located in the ICA from the petrous through the superior hypophyseal segments; and (3) Is a fusiform or saccular wide-necked IA with one of the following characteristics: (a) Small (< 5 mm) or medium (>5-10 mm) size with a neck width ≥ 4.0 mm or a dome-to-neck ratio of < 2; OR (b) Large (>10-25 mm) or giant (>25 mm) size

You may not qualify if…

A subarachnoid or intracerebral hemorrhage in the 60 days preceding the index procedure
A bleeding disorder or a platelet count of less than 100x103/mm3 or INR >1.5
A contraindication to or inability to tolerate antiplatelet therapy
An allergy to radiographic contrast agents
An allergy to nickel, titanium, platinum, tungsten, or stainless steel
An allergy to local or general anesthesia
A history of untreated atrial fibrillation, untreated/uncontrollable hypertension, or other stroke risk factors
A history of deep vein thrombosis or pulmonary embolism
A history of heart failure, dilated cardiomyopathy, or congenital heart conditions
Hypercoagulopathy or a hemorrhagic or coagulation deficiency refractory to medical therapy or subject refuses treatment with blood products
Suffered a stroke within 180 days preceding the index procedure
Had major surgery within the 30 days preceding or planned for the 180 days following the index procedure, including but not limited to intracranial stenting or coiling
Target aneurysm has been previously treated with clipping, coiling, or flow diversion
Had previous stenting of or implant in parent artery proximal to the target aneurysm that could interfere with delivery or performance of study device
Asymptomatic extradural aneurysms requiring treatment
Contraindication to computed tomography (CT) or magnetic resonance (MR)
An unstable neurological deficit (i.e., worsening of a clinical condition within the 30 days preceding the index procedure)
Evidence of an active systemic infection (including COVID-19) at index procedure
Dementia or other cognitive condition limiting their ability to participate in the study
A condition that may limit survival to less than 12 months post-index procedure
Serum creatinine ≥2.5 mg/dL
Had radiation or chemotherapy treatment either currently or within the 60 days preceding the index procedure
Current enrollment in a separate clinical trial
Another condition(s) that, in the opinion of the Investigator, could interfere with the ability to perform a safe or effective procedure
Current pregnancy or plan to become pregnant within the 12 months following the index procedure, or be currently breastfeeding

Where it is running

Hospital Universitari Vall d'Hebron — Barcelona, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.